Voloridge Investment Management
ASMB icon

Voloridge Investment Management’s Assembly Biosciences ASMB Stock Holding History

Voloridge Investment Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,919
Closed -$648K – 1375
2020
Q4 		$648K Buy
+8,919
New +$1.05M 0.01% 1081
2020
Q1 		– Sell
-3,713
Closed -$912K – 1082
2019
Q4 		$912K Buy
3,713
+807
+28% +$149K 0.02% 676
2019
Q3 		$343K Buy
2,906
+1,507
+108% +$228K 0.01% 894
2019
Q2 		$226K Buy
+1,399
New +$266K 0.01% 687

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Voloridge Investment Management's ASMB Position: Q1 2021 in Review

Voloridge Investment Management sold out of Assembly Biosciences (ASMB) in Q1 2021, closing a stake of 8,919 shares — an estimated $648K sold.

Voloridge Investment Management first reported a position in ASMB in Q2 2019 and held it in 4 quarters. The position peaked at $912K in Q4 2019. 107 funds tracked by Wall St. Rank hold ASMB as of Q1 2021.

  • Voloridge Investment Management reported no remaining Assembly Biosciences position as of Q1 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 8,919 Assembly Biosciences shares in Q1 2021, an estimated $648K.
  • Voloridge Investment Management first reported a position in Assembly Biosciences in Q2 2019 and held it in 4 quarters.
  • Voloridge Investment Management's Assembly Biosciences position peaked at $912K in Q4 2019.
  • 107 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2021.

Based on Voloridge Investment Management's 13F filing for Q1 2021, filed 17 May 2021.